William Hunt MD

Department of Medicine
Associate Professor

randy.hunt@emory.edu

Emory Adult Cystic Fibrosis Program
1605 Chantilly Drive, Suite 392

Overview

Dr. Hunt is an Associate Professor of Medicine in the Division of Pulmonary, Allergy, Critical Care and Sleep. His clinical interest include cystic fibrosis and non-cystic fibrosis bronchiectasis, point-of-care ultrasonography and lung transplantation. He is involved in the outpatient evaluation and management for lung transplantation for advanced lung diseases as well as inpatient care of patients after lung transplantation. His research interests focus on understanding the complex interactions of diabetes on lung dysfunction and the immune system, particular in cystic fibrosis.

Academic Appointment

Associate Professor, Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University

Education

Degrees

B.S from Furman University
MD from Medical University of South Carolina

Research

Publications

Vitamin D status in young adults with cystic fibrosis on highly effective CFTR modulator therapy.
J Steroid Biochem Mol Biol Volume: 253 Page(s): 106810
10/01/2025 Authors: Cobb C; Alvarez JA; Hunt WR; Daley T; Bai S; Tangpricha V
Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocol.
PLoS One Volume: 20 Page(s): e0316721
01/01/2025 Authors: Swenson CE; Hunt WR; Manfredi C; Beltran DJ; Hong JS; Davis BR; Suzuki S; Barill C; Rab A; Chico C
Hypogonadism in a Man With Cystic Fibrosis and an Unusually Low Serum Testosterone: A Cautionary Tale.
AACE Clin Case Rep Volume: 11 Page(s): 32 - 35
01/01/2025 Authors: Lertdetkajorn K; Cobb C; Kapolka RJ; Hunt WR; Tangpricha V
Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study.
BMJ Open Volume: 14 Page(s): e092503
12/26/2024 Authors: Zaveri S; Stecenko A; Hunt WR; Goss A; Sharma P; Hartman TJ; Easley K; Chandler JD; Burley TM; Driggers C
Perception and participation in sport and exercise in cystic fibrosis: The impact of CFTR modulators.
Respir Med Volume: 235 Page(s): 107840
12/01/2024 Authors: Berthold A; Barr E; Kasi A; Lichten L; Hunt WR
Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial.
Lancet Respir Med Volume: 12 Page(s): 947 - 957
12/01/2024 Authors: Solomon GM; Linnemann RW; Rich R; Streby A; Buehler B; Hunter E; Vijaykumar K; Hunt WR; Brewington JJ; Rab A
Testosterone concentrations and associated predictors in men with cystic fibrosis: A retrospective, single-center study.
Am J Med Sci Volume: 368 Page(s): 637 - 647
12/01/2024 Authors: Jathal I; Wang Y; Binongo JNG; Cobb C; Hunt WR; Khan FN; Tangpricha V
Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis.
Am J Respir Crit Care Med Volume: 210 Page(s): 1155 - 1158
11/01/2024 Authors: Morgan SJ; Nichols DP; Ni W; Hong G; Salipante SJ; Solomon GM; Rowe SM; Clancy JP; Cramer RA; Singh PK
Impact of high-dose cholecalciferol (vitamin D3) and inulin prebiotic on intestinal and airway microbiota in adults with cystic fibrosis: A 22 randomized, placebo-controlled, double-blind pilot study.
J Clin Transl Endocrinol Volume: 37 Page(s): 100362
09/01/2024 Authors: Suppakitjanusant P; Wang Y; Sivapiromrat AK; Hu C; Binongo J; Hunt WR; Weinstein S; Jathal I; Alvarez JA; Chassaing B
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
Hepatology Volume: 79 Page(s): 1220 - 1238
05/01/2024 Authors: Sellers ZM; Assis DN; Paranjape SM; Sathe M; Bodewes F; Bowen M; Cipolli M; Debray D; Green N; Hughan KS
Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis.
Contemp Clin Trials Commun Volume: 38 Page(s): 101278
04/01/2024 Authors: Sivapiromrat AK; Suppakitjanusant P; Wang Y; Hu C; Binongo J; Hunt WR; Weinstein S; Jathal I; Alvarez JA; Chassaing B
Vitamin D for glycemic control following an acute pulmonary exacerbation: A secondary analysis of a multicenter, double-blind, randomized, placebo-controlled trial in adults with cystic fibrosis.
medRxiv
03/10/2024 Authors: Sivapiromrat AK; Hunt WR; Alvarez JA; Ziegler TR; Tangpricha V
Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D Trial) in adults with cystic fibrosis.
medRxiv
01/05/2024 Authors: Sivapiromrat AK; Suppakitjanusant P; Wang Y; Binongo J; Hunt WR; Gewirtz A; Alvarez JA; Hu C; Weinstein S; Jathal I
Pulmonary Function and Quality of Life in Adults with Cystic Fibrosis.
Lung Volume: 201 Page(s): 635 - 639
12/01/2023 Authors: Smirnova N; Lowers J; Magee MJ; Auld SC; Hunt WR; Fitzpatrick A; Lama V; Kavalieratos D
Vitamin D to prevent bone loss during acute pulmonary exacerbation: More study is needed.
Bone Volume: 177 Page(s): 116894
12/01/2023 Authors: Wu M; Bhimavarapu A; Alvarez JA; Hunt WR; Tangpricha V
Changes in bone turnover after high-dose vitamin D supplementation during acute pulmonary exacerbation in cystic fibrosis.
Bone Volume: 174 Page(s): 116835
09/01/2023 Authors: Wu M; Bhimavarapu A; Alvarez JA; Hunt WR; Tangpricha V
Author Correction: Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD).
Sci Rep Volume: 13 Page(s): 10707
07/03/2023 Authors: Suppakitjanusant P; Kasemkosin N; Sivapiromrat AK; Weinstein S; Ongphiphadhanakul B; Hunt WR; Sueblinvong V; Tangpricha V
Predicting glycemic control status and high blood glucose levels through voice characteristic analysis in patients with cystic fibrosis-related diabetes (CFRD).
Sci Rep Volume: 13 Page(s): 8617
05/27/2023 Authors: Suppakitjanusant P; Kasemkosin N; Sivapiromrat AK; Weinstein S; Ongphiphadhanakul B; Hunt WR; Sueblinvong V; Tangpricha V
Prevalence of unmet pain and symptom management needs in adults with cystic fibrosis.
J Cyst Fibros Volume: 22 Page(s): 352 - 355
03/01/2023 Authors: Dubin E; Lowers J; Dellon EP; Hempstead S; Faro A; Tallarico E; Fitzpatrick A; Hunt WR; Kavalieratos D
Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis.
Front Nutr Volume: 10 Page(s): 1158452
01/01/2023 Authors: Daley TC; Cousineau BA; Nesbeth P-DC; Ivie EA; Bellissimo MP; Easley KA; Vellanki P; Vos MB; Hunt WR; Stecenko AA
Integrating specialist palliative care to improve care and reduce suffering: cystic fibrosis (InSPIRe:CF) - study protocol for a multicentre randomised clinical trial.
BMJ Open Respir Res Volume: 9
09/01/2022 Authors: Lowers J; Dellon EP; Stephenson A; Arnold R; Althouse A; Jeong K; Dubin E; Soodalter J; Hovater C; Bakitas M
"Awareness of the Total Suffering": Existential Distress in Cystic Fibrosis
Volume: 205
05/01/2022 Authors: Smirnova N; Dubin E; Dellon EP; Hunt WR; Kavalieratos D
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial.
Am J Respir Crit Care Med Volume: 205 Page(s): 529 - 539
03/01/2022 Authors: Nichols DP; Paynter AC; Heltshe SL; Donaldson SH; Frederick CA; Freedman SD; Gelfond D; Hoffman LR; Kelly A; Narkewicz MR
Use of estrogen supplementation is associated with higher quality of life scores in women with cystic fibrosis.
J Clin Transl Endocrinol Volume: 27 Page(s): 100292
03/01/2022 Authors: Wu M; Arora N; Sueblinvong V; Hunt WR; Tangpricha V
A medium composition containing normal resting glucose that supports differentiation of primary human airway cells.
Sci Rep Volume: 12 Page(s): 1540
01/27/2022 Authors: Morgan R; Manfredi C; Easley KF; Watkins LD; Hunt WR; Goudy SL; Sorscher EJ; Koval M; Molina SA
Evaluating Differences in the Disease Experiences of Minority Adults With Cystic Fibrosis.
J Patient Exp Volume: 9 Page(s): 23743735221112629
01/01/2022 Authors: Hutchins K; Barr E; Bellcross C; Ali N; Hunt WR
Formal vs. informal transition in adolescents with cystic fibrosis: A retrospective comparison of outcomes.
J Pediatr Nurs Volume: 62 Page(s): 177 - 183
01/01/2022 Authors: Middour-Oxler B; Bergman S; Blair S; Pendley S; Stecenko A; Hunt WR
Assessment of a novel genetic counselling intervention to inform assisted reproductive technology treatments and other family-building options in adults with cystic fibrosis.
Reprod Biomed Soc Online Volume: 13 Page(s): 37 - 45
08/01/2021 Authors: Kushary S; Ali N; Spencer JB; Dokson J; Hunt WR
COMPLICATIONS ASSOCIATED WITH A CLASSIC CASE OF TUBEROUS SCLEROSIS
Volume: 36 Page(s): S321 - S321
07/01/2021 Authors: Soti S; Hunt WR
A Large Single Center's Clinical Experience with Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis and a Baseline FEV1 of Less Than 40 Percent Predicted
Volume: 203
05/01/2021 Authors: Kapolka R; Hunt WR
ESTROGEN SUPPLEMENTATION IS ASSOCIATED WITH HIGHER QUALITY OF LIFE SCORES IN WOMEN WITH CYSTIC FIBROSIS
Volume: 69 Page(s): 437 - 437
02/01/2021 Authors: Wu M; Arora N; Sueblinvong V; Hunt WR; Tangpricha V
Transition Planning for Chronic Illnesses in the Time of COVID-19.
J Patient Exp Volume: 7 Page(s): 848 - 850
12/01/2020 Authors: Hunt WR; Linnemann RW; Middour-Oxler B
Relationship Between Estrogen Treatment and Skeletal Health in Women With Cystic Fibrosis.
Am J Med Sci Volume: 360 Page(s): 581 - 590
11/01/2020 Authors: Wu M; Bettermann EL; Arora N; Hunt WR; McCracken C; Tangpricha V
MULTIDISCIPLINARY TELEHEALTH CLINIC VISITS DURING COVID-19 PANDEMIC
Volume: 55 Page(s): S314 - S314
10/01/2020 Authors: Schiff S; Riley P; Grant D; Hilaire M; Blair SD; Barr E; Hubbard-Green D; Hunt WR
MUSCLE HEALTH CONTRIBUTES TO GREATER QUALITY OF LIFE IN ADULTS WITH CYSTIC FIBROSIS
Volume: 55 Page(s): S255 - S256
10/01/2020 Authors: Crain BH; Bellissimo MP; Ivie EA; Hunt WR; Ziegler TR; Harris RA; Alvarez JA
IMPACT OF ESTROGEN ON QUALITY OF LIFE AND BONE ACCRUAL FOR WOMEN WITH CF
Volume: 55 Page(s): S85 - S85
10/01/2020 Authors: Wu M; Bettermann E; Arora N; Hunt WR; Tirouvanziam R; McCracken C; Tangpricha V
Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density.
J Clin Transl Endocrinol Volume: 20 Page(s): 100223
06/01/2020 Authors: Wu M; Hunt WR; Putman MS; Tangpricha V
Glucose ingestion in cystic fibrosis induces severe redox imbalance: A potential role in diabetes.
J Cyst Fibros Volume: 19 Page(s): 476 - 482
05/01/2020 Authors: Hunt WR; Hansen JM; Stecenko AA
An Elusive Case of Candida Meningitis Following Lung Transplantation
Volume: 201
01/01/2020 Authors: Kapolka R; Hunt WR
Incidentally Detected Malignancies in Lung Transplant Explants.
Transplant Direct Volume: 5 Page(s): e503
11/01/2019 Authors: Amratia DA; Hunt WR; Neujahr D; Veeraraghavan S
SKELETAL AND REPRODUCTIVE HEALTH IN PREMENOPAUSAL WOMEN WITH CF
Volume: 54 Page(s): S227 - S227
10/01/2019 Authors: Wu M; Hunt WR; Tirouvanziam R; Tangpricha V
FEASIBILITY OF USING ELECTRONIC MEDICAL RECORDS TO ASSESS BODY COMPOSITION IN CYSTIC FIBROSIS
Volume: 54 Page(s): S259 - S259
10/01/2019 Authors: Rodriguez-Badillo V; Nguyen KT; Bellissimo MP; Ziegler TR; Hunt WR; Alvarez JA
LISTENING TO THE VOICE OF EXPERIENCE: LESSONS FROM POST-LUNG TRANSPLANT INDIVIDUALS WITH CYSTIC FIBROSIS
Volume: 54 Page(s): S471 - S471
10/01/2019 Authors: Blair SD; Middour-Oxler B; Sinha CB; Hunt WR
LUNG TRANSPLANT PERCEPTIONS AND PREFERENCES OF INDIVIDUALS WITH CYSTIC FIBROSIS AND THEIR CAREGIVERS
Volume: 54 Page(s): S472 - S472
10/01/2019 Authors: Middour-Oxler B; Blair SD; Hunt WR
IMPROVING OUTCOMES THROUGH OPTIMIZING OGTT AND ANNUAL LAB ADHERENCE
Volume: 54 Page(s): S439 - S440
10/01/2019 Authors: Riley P; Grant D; Hubbard-Green D; Hyman S; Blair SD; Hilaire M; Henry B; Grady A; Hunt WR
SHAPING TRANSITION PROGRAM COMPONENTS WITH PRE-TRANSITION AND POST-TRANSITION SURVEY RESULTS TO INCREASE PARTNERING
Volume: 54 Page(s): S396 - S397
10/01/2019 Authors: Middour-Oxler B; Blair SD; Hunt WR
INTEGRATING TELEBEHAVIORAL HEALTH SERVICES IN AN ADULT CYSTIC FIBROSIS CLINIC: A PILOT PROGRAM
Volume: 54 Page(s): S399 - S400
10/01/2019 Authors: Blair SD; Hunt WR
Visceral adipose tissue is associated with poor diet quality and higher fasting glucose in adults with cystic fibrosis.
J Cyst Fibros Volume: 18 Page(s): 430 - 435
05/01/2019 Authors: Bellissimo MP; Zhang I; Ivie EA; Tran PH; Tangpricha V; Hunt WR; Stecenko AA; Ziegler TR; Alvarez JA
A RETROSPECTIVE COHORT STUDY EXPLORING ANXIETY AND DEPRESSION IN INDIVIDUALS WITH CYSTIC FIBROSIS UNDERGOING PEDIATRIC TO ADULT CARE TRANSITION
Volume: 53 Page(s): 432 - 432
09/01/2018 Authors: Blair SD; Hunt WR; Middour-Oxler B
COMPARISON OF A SELF-DIRECTED EDUCATIONAL MODULE ON GENETICS TO IN-PERSON COUNSELING FOR CYSTIC FIBROSIS ADOLESCENTS
Volume: 53 Page(s): 447 - 447
09/01/2018 Authors: Pendley SL; Lusk L; Kaplan ET; Hunt WR; Stecenko A; Bellcross C; Wei J
KNOWLEDGE AND PERCEPTIONS OF ASSISTED REPRODUCTIVE TECHNOLOGIES AND OTHER FAMILY BUILDING OPTIONS IN ADULTS WITH CYSTIC FIBROSIS
Volume: 53 Page(s): 447 - 448
09/01/2018 Authors: Kushary S; Ali N; Spencer J; Dukson J; Hunt WR
POOR DIET QUALITY IS ASSOCIATED WITH HIGHER TOTAL AND VISCERAL ADIPOSE TISSUE IN ADULTS WITH CYSTIC FIBROSIS
Volume: 53 Page(s): 397 - 397
09/01/2018 Authors: Zhang I; Bellissimo MP; Ivie EA; Tran PH; Hunt WR; Stecenko A; Ziegler TR; Alvarez JA
Incidental Pathological Detection of Malignancy in Lung Transplant Explants: A Single Center Study
Volume: 197
01/01/2018 Authors: Amratia D; Hunt WR; Neujahr D; Veeraraghavan S
THE EFFECT OF BONE MINERAL DENSITY ON LUNG TRANSPLANTATION OUTCOMES IN ADULTS WITH CYSTIC FIBROSIS
Volume: 52 Page(s): S468 - S469
09/01/2017 Authors: Ali H; Ajani S; Cohen LA; Neujahr D; Hurtik M; Hunt WR
MENTAL HEALTH AND PULMONARY OUTCOMES IN CF ADOLESCENTS AND ADULTS
Volume: 52 Page(s): S494 - S494
09/01/2017 Authors: Linnemann RW; Blair SD; Hunt WR; Walker SD; Stecenko A
PROSPECTIVE ASSESSMENT OF TRANSITION ANXIETY AND SELF-PERCEIVED READINESS IN A LARGE CF CENTER
Volume: 52 Page(s): S508 - S508
09/01/2017 Authors: Middour-Oxler B; Blair SD; Pendley S; Crews BM; Walker SD; Stecenko A; Hunt WR
PAST, PRESENT, AND FUTURE DIRECTIONS OF A MULTI-SITE TRANSITION PROGRAM FOR ADOLESCENTS WITH CYSTIC FIBROSIS
Volume: 52 Page(s): S507 - S507
09/01/2017 Authors: Middour-Oxler B; Blair SD; Pendley S; Crews BM; Stecenko A; Hunt WR
INCREASED TGF beta 1 IN CFTR MUTATED ALVEOLAR MACROPHAGE DYSREGULATES VIRAL DEFENSE AND INFLAMMASOME ACTIVATION
Volume: 52 Page(s): S252 - S252
09/01/2017 Authors: Hunt WR; Ping XD; Gauthier TW
PARTICIPATION IN A FORMALIZED CF TRANSITION PROGRAM IS ASSOCIATED WITH DECREASED PULMONARY EXACERBATIONS
Volume: 52 Page(s): S508 - S508
09/01/2017 Authors: Hunt WR; Bergman S; Middour-Oxler B
A novel presentation of Mycobacterium avium complex in a recipient of a lung transplant: a case report.
J Med Case Rep Volume: 11 Page(s): 240
08/28/2017 Authors: Cohen L; Guarner J; Hunt WR
Pulmonary Mucormycosis in a Patient With Poorly Controlled Diabetes After a Liver Transplant.
Am J Med Sci Volume: 354 Page(s): e1
08/01/2017 Authors: Hunt WR
Insulin signaling via the PI3-kinase/Akt pathway regulates airway glucose uptake and barrier function in a CFTR-dependent manner.
Am J Physiol Lung Cell Mol Physiol Volume: 312 Page(s): L688 - L702
05/01/2017 Authors: Molina SA; Moriarty HK; Infield DT; Imhoff BR; Vance RJ; Kim AH; Hansen JM; Hunt WR; Koval M; McCarty NA
A RETROSPECTIVE SURVEY OF PATIENT EXPERIENCE WITH PEDIATRIC TO ADULT TRANSITION OF CF CARE
PEDIATRIC PULMONOLOGY Volume: 51 Page(s): 477 - 478
10/01/2016 Authors: Middour-Oxler BJ; Bergman S; Blair SD; Pendley S; Crews B; Siragusa A; Walker SD; Stecenko A; Hunt WR
PREDIABETES AND REDOX IMBALANCE IN YOUNG CHILDREN WITH CF
PEDIATRIC PULMONOLOGY Volume: 51 Page(s): 445 - 445
10/01/2016 Authors: Hunt WR; Guentert DE; Brown LS; Stecenko A
DISEASE-SPECIFIC GENETIC KNOWLEDGE IN ADOLESCENTS WITH CYSTIC FIBROSIS AND THEIR PARENTS
PEDIATRIC PULMONOLOGY Volume: 51 Page(s): 483 - 483
10/01/2016 Authors: Kaplan ET; Blair SD; Fitzpatrick A; Hunt WR; Pendley S; Wei JW; Stecenko A
EXPERIENCE OF A LARGE ACADEMIC CF CENTER WITH LUMACAFTOR/IVACAFTOR
PEDIATRIC PULMONOLOGY Volume: 51 Page(s): 302 - 302
10/01/2016 Authors: Walker SD; Henry B; Sueblinvong V; Hunt WR
Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function.
J Cyst Fibros Volume: 15 Page(s): 681 - 688
09/01/2016 Authors: Hunt WR; Helfman BR; McCarty NA; Hansen JM
An Endobronchial Mass In A Patient Post Bilateral Lung Transplant
Volume: 193
01/01/2016 Authors: Cohen LA; Hunt WR
BUILDING A CASE FOR INCREASED CF CENTER STAFF
PEDIATRIC PULMONOLOGY Volume: 50 Page(s): 392 - 393
10/01/2015 Authors: Walker SD; Martin M; Hunt WR
METABOLIC ANALYSIS OF EXHALED BREATH CONDENSATE IN CYSTIC FIBROSIS-RELATED DIABETES
PEDIATRIC PULMONOLOGY Volume: 49 Page(s): 424 - 424
09/01/2014 Authors: Hunt WR; Stecenko AA; Tran VT; McCarty NA; Jones DP; Hansen JM
ADVANCED GLYCATION END PRODUCTS ARE ELEVATED IN CYSTIC FIBROSIS RELATED DIABETES
PEDIATRIC PULMONOLOGY Volume: 49 Page(s): 424 - 424
09/01/2014 Authors: Hunt WR; Helfman BR; McCarty NA; Hansen JM
Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke.
Pulm Circ Volume: 4 Page(s): 260 - 268
06/01/2014 Authors: Brown MB; Hunt WR; Noe JE; Rush NI; Schweitzer KS; Leece TC; Moldobaeva A; Wagner EM; Dudek SM; Poirier C
Patient Inhaler Education And Assessment Of Knowledge In A Pulmonary Fellow Led Outpatient Ward Service: The Peak Flow Study
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Volume: 189
01/01/2014 Authors: Hunt WR; Staitieh B; Lodi US; Wongtrakool C; Schulman D
Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
Am J Physiol Lung Cell Mol Physiol Volume: 306 Page(s): L43 - L49
01/01/2014 Authors: Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
EXTRACELLULAR PULMONARY REDOX IMBALANCE IN A MURINE MODEL OF CYSTIC FIBROSIS RELATED DIABETES
PEDIATRIC PULMONOLOGY Volume: 48 Page(s): 418 - 419
10/01/2013 Authors: Hunt WR; Zughaier SM; Guentert DE; Koval M; McCarty NA; Hansen JM
HIGH GLUCOSE LEVELS DYSREGULATE NGAL EXPRESSION IN CFTR-DEFICIENT MACROPHAGES
PEDIATRIC PULMONOLOGY Volume: 48 Page(s): 251 - 251
10/01/2013 Authors: Zughaier SM; Guentert DE; Hunt WR; Hansen JM; McCarty NA
A 22-year-old woman with bronchiectasis and a mediastinal mass.
Chest Volume: 144 Page(s): 1406 - 1409
10/01/2013 Authors: Hunt WR; Allam JS; Sica G; Little BP; Veeraraghavan S
Pulmonary Fellows' Assessment Of A Standardized Sign-Out: The Pass Project
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Volume: 187
01/01/2013 Authors: Hunt WR; Staitieh B; Finklea JD; Han J; Schulman DA
ELEVATED AIRWAY AND SYSTEMIC GLUCOSE IMPEDES LUNG BACTERIAL CLEARANCE IN A MURINE MODEL OF CYSTIC FIBROSIS RELATED DIABETES
PEDIATRIC PULMONOLOGY Volume: 47 Page(s): 421 - 421
09/01/2012 Authors: Hunt WR; Zughaier SM; Shenep M; McCarty NA; Hansen JM
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITION ALTERS LUNG ENDOTHELIAL CELL BARRIER FUNCTION
PEDIATRIC PULMONOLOGY Page(s): 238 - 238
01/01/2010 Authors: Brown M; Hunt WR; Noe J; Rush N; Schweitzer KS; Moldobaeva A; Wagner E; Dudek S; Petrache I
The role of the cystic fibrosis transmembrane conductance regulator (CFTR) in the maintenance of lung endothelial cell barrier function
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Volume: 181
01/01/2010 Authors: Hunt WR; Noe J; Rush NI; Schweitzer K; Moldobaeva A; Wagner E; Dudek SM; Petrache I

Directory section navigation

Profile